Point-of-care Ultrasound Market (By Type: Diagnostic, Therapeutic; By Portability: Trolley-Based Devices, Handheld Devices; By Application: Emergency Medicine, Cardiology, Obstetrics & Gynecology, Urology, Vascular Surgery, Musculoskeletal; By End users: Hospitals, Clinics, Maternity Centers, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Point-of-care Ultrasound Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Point-of-care Ultrasound Market Revenue and Volume Forecast, by Type, 2024-2033
8.1.1. Diagnostic
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Therapeutic
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1. Point-of-care Ultrasound Market Revenue and Volume Forecast, by Portability, 2024-2033
9.1.1. Trolley-Based Devices
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Handheld Devices
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1. Point-of-care Ultrasound Market Revenue and Volume Forecast, by Application, 2024-2033
10.1.1. Emergency Medicine
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Cardiology
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Obstetrics & Gynecology
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Urology
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Vascular Surgery
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Musculoskeletal
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
11.1. Point-of-care Ultrasound Market Revenue and Volume Forecast, by End users, 2024-2033
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Clinics
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Maternity Centers
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
11.1.5. Others
11.1.5.1. Market Revenue and Volume Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by End users (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by Portability (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by End users (2021-2033)
13.1. Koninklijke Philips N.V.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. GE Healthcare
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. FUJIFILM Sonosite, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Hitachi Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. ALPINION MEDICAL SYSTEMS Co., Ltd
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Terason Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. EDAN Instruments
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Esaote S.p.A
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Butterfly Network Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client